Hai-O Enterprise Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hai-O Enterprise Berhad with three other
drug stores in Asia:
Hua Xia Healthcare Holdings Limited
of Hong Kong
sales of 269.52 million Hong Kong Dollars [US$34.47 million]
of which 348%
was Pharmaceutical Wholesale),
Hong Kong Life Sciences and Technologies Group Ltd
of Hong Kong
(153.57 million Hong Kong Dollars [US$19.64 million]
of which 79%
was Trading Business), and
Hin Sang Group (International) Holding Co Ltd
based in Hong Kong
(201.82 million Hong Kong Dollars [US$25.81 million]
of which 89%
was Product Development Segment).
Hai-O Enterprise Berhad reported sales of 404.24 million Malaysian Ringgits (US$96.48 million)
April of 2017.
increase of 35.8%
versus 2016, when the company's sales were 297.63 million Malaysian Ringgits.
Sales of Multi-Level Marketing saw an increase
55.8% in 2017, from
198.28 million Malaysian Ringgits to 308.95 million Malaysian Ringgits.
Not all segments of Hai-O Enterprise Berhad experienced an increase in sales in 2017:
sales of Others fell 32.8% to 4.50 million Malaysian Ringgits.
(However, this segment's sales were only a very small portion of the company's overall sales).
Hai-O Enterprise Berhad also experienced decreases in sales in
Wholesale (down 3.1% to 52.65 million Malaysian Ringgits)
Retail (down 0.4% to 38.15 million Malaysian Ringgits)